Evidence map›Paper›PMID 21951545›Full record

ArticleMethods in cell biology2011

Using the zebrafish photomotor response for psychotropic drug screening.

David Kokel, Randall T Peterson

Abstract read
In one paragraph

Article in Methods in cell biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
6.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Multi-Behavioral Endpoint Testing of an 87-Chemical Compound Library in Freshwater Planarians.Toxicological sciences : an official journal of the Society of Toxicology · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

David KokelCardiovascular Research Center and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, USA.
Randall T Peterson
Harvard University · USMassachusetts General Hospital · US

Funding

In Vivo Discovery of Psychotropic Drugs by High-Throughput Behavioral PhenotypingR01MH086867 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PETERSON, RANDALL T · 2009 to 2012
$1.4M
High-throughput behavior-based dopaminergic drug discovery in the zebrafishK01MH091449 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KOKEL, DAVID · 2010 to 2014
$931k
High-throughput behavioral screening for in vivo discovery of neuroactive drugsR21MH085205 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PETERSON, RANDALL T · 2009 to 2009
$265k
NIMH NIH HHS K01 MH091449NIMH NIH HHS MH085206NIMH NIH HHS MH086867NIMH NIH HHS R01 MH086867NIMH NIH HHS R21 MH085205
6 · The paper itself

Abstract

Because psychotropic drugs affect behavior, we can use changes in behavior to discover psychotropic drugs. The original prototypes of most neuroactive medicines were discovered in humans, rodents and other model organisms. Most of these discoveries were made by chance, but the process of behavior based drug discovery can be made more systematic and efficient. Fully automated platforms for analyzing the behavior of embryonic zebrafish capture digital video recordings of animals in each individual well of a 96-well plate before, during, and after a series of stimuli. To analyze systematically the thousands of behavioral recordings obtained from a large-scale chemical screen, we transform these behavioral recordings into numerical barcodes, providing a concise and interpretable summary of the observed phenotypes in each well. Systems-level analysis of these behavioral phenotypes generate testable hypotheses about the molecular mechanisms of poorly understood drugs and behaviors. By combining the in vivo relevance of behavior-based phenotyping with the scale and automation of modern drug screening technologies, systematic behavioral barcoding represents a means of discovering psychotropic drugs and provides a powerful, systematic approach for unraveling the complexities of vertebrate behavior.

Indexed as

High-Throughput Screening AssaysAlgorithmsAnimalsAntipsychotic AgentsAutomation, LaboratoryBehavior, AnimalDark AdaptationDrug DiscoveryDrug Evaluation, PreclinicalEmbryo, NonmammalianHumansInfrared RaysMotor ActivityPhenotypePsychotic DisordersResearch DesignAntipsychotic AgentsSmall Molecule Libraries

Identifiers

PMID21951545
PMCPMC3635141
OpenAlexW1509773760

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.